284 related articles for article (PubMed ID: 27872236)
1. Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2).
Bogman K; Schwab D; Delporte ML; Palermo G; Amrein K; Mohr S; De Vera Mudry MC; Brown MJ; Ferber P
Hypertension; 2017 Jan; 69(1):189-196. PubMed ID: 27872236
[TBL] [Abstract][Full Text] [Related]
2. Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human.
Cerny MA; Csengery A; Schmenk J; Frederick K
J Steroid Biochem Mol Biol; 2015 Nov; 154():197-205. PubMed ID: 26303746
[TBL] [Abstract][Full Text] [Related]
3. Rhesus monkey model for concurrent analyses of in vivo selectivity, pharmacokinetics and pharmacodynamics of aldosterone synthase inhibitors.
Cai TQ; Stribling S; Tong X; Xu L; Wisniewski T; Fontenot JA; Struthers M; Akinsanya KO
J Pharmacol Toxicol Methods; 2015; 71():137-46. PubMed ID: 25304940
[TBL] [Abstract][Full Text] [Related]
4. Disorders of the aldosterone synthase and steroid 11beta-hydroxylase deficiencies.
Peter M; Dubuis JM; Sippell WG
Horm Res; 1999; 51(5):211-22. PubMed ID: 10559665
[TBL] [Abstract][Full Text] [Related]
5. The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation.
Connell JM; Fraser R; MacKenzie SM; Friel EC; Ingram MC; Holloway CD; Davies E
Mol Cell Endocrinol; 2004 Mar; 217(1-2):243-7. PubMed ID: 15134824
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone synthase inhibition in humans.
Azizi M; Amar L; Menard J
Nephrol Dial Transplant; 2013 Jan; 28(1):36-43. PubMed ID: 23045428
[TBL] [Abstract][Full Text] [Related]
7. LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase.
Sloan-Lancaster J; Raddad E; Flynt A; Jin Y; Voelker J; Miller JW
J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317717883. PubMed ID: 28814143
[TBL] [Abstract][Full Text] [Related]
8. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
9. Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): screening in fission yeast and evaluation of selectivity in V79 cells.
Ehmer PB; Bureik M; Bernhardt R; Müller U; Hartmann RW
J Steroid Biochem Mol Biol; 2002 Jun; 81(2):173-9. PubMed ID: 12137808
[TBL] [Abstract][Full Text] [Related]
10. Effects of 18-hydroxylated steroids on corticosteroid production by human aldosterone synthase and 11beta-hydroxylase.
Fisher A; Friel EC; Bernhardt R; Gomez-Sanchez C; Connell JM; Fraser R; Davies E
J Clin Endocrinol Metab; 2001 Sep; 86(9):4326-9. PubMed ID: 11549669
[TBL] [Abstract][Full Text] [Related]
11. Dietary potassium supplementation and sodium restriction stimulate aldosterone synthase but not 11 beta-hydroxylase P-450 messenger ribonucleic acid accumulation in rat adrenals and require angiotensin II production.
Tremblay A; Parker KL; Lehoux JG
Endocrinology; 1992 Jun; 130(6):3152-8. PubMed ID: 1597135
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone.
Rigel DF; Fu F; Beil M; Hu CW; Liang G; Jeng AY
J Pharmacol Exp Ther; 2010 Jul; 334(1):232-43. PubMed ID: 20354176
[TBL] [Abstract][Full Text] [Related]
13. Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity.
Meyers K; Cogan DA; Burke J; Arenas R; Balestra M; Brown NF; Chen Z; Cerny MA; Clifford HE; Colombo F; Fader L; Frederick KS; Guo X; Goldberg D; Hornberger KR; Kugler S; Lord J; Marshall DR; Moss N; Parmentier JH; Richman JR; Schmenk J; Weldon SM; Yu M; Zhang M
Bioorg Med Chem Lett; 2018 Mar; 28(5):979-984. PubMed ID: 29254646
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.
Nishimoto K; Koga M; Seki T; Oki K; Gomez-Sanchez EP; Gomez-Sanchez CE; Naruse M; Sakaguchi T; Morita S; Kosaka T; Oya M; Ogishima T; Yasuda M; Suematsu M; Kabe Y; Omura M; Nishikawa T; Mukai K
Mol Cell Endocrinol; 2017 Feb; 441():124-133. PubMed ID: 27751767
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism.
Amar L; Azizi M; Menard J; Peyrard S; Watson C; Plouin PF
Hypertension; 2010 Nov; 56(5):831-8. PubMed ID: 20837883
[TBL] [Abstract][Full Text] [Related]
16. The development of hypertension and hyperaldosteronism in a rodent model of life-long obesity.
Northcott CA; Fink GD; Garver H; Haywood JR; Laimon-Thomson EL; McClain JL; Pires PW; Rainey WE; Rigsby CS; Dorrance AM
Endocrinology; 2012 Apr; 153(4):1764-73. PubMed ID: 22355066
[TBL] [Abstract][Full Text] [Related]
17. Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronism.
van Rooyen D; Lerario AM; Little DW; Ullenbruch MR; Taylor MJ; Gomez-Sanchez CE; Hammer GD; Rainey WE
Mol Cell Endocrinol; 2024 May; 585():112176. PubMed ID: 38341019
[TBL] [Abstract][Full Text] [Related]
18. Identification of sulfonylpyrimidines as novel selective aldosterone synthase (CYP11B2) inhibitors.
Meguro M; Miyauchi S; Kanao-Arisumi Y; Naito S; Suzuki K; Inoue S; Yamada K; Homma T; Chiba K; Nara F; Furuzono S
Bioorg Med Chem; 2024 Jun; 108():117775. PubMed ID: 38851000
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy.
Schumacher CD; Steele RE; Brunner HR
J Hypertens; 2013 Oct; 31(10):2085-93. PubMed ID: 24107737
[TBL] [Abstract][Full Text] [Related]
20. Functional maturation of the primate fetal adrenal in vivo: 3. Specific zonal localization and developmental regulation of CYP21A2 (P450c21) and CYP11B1/CYP11B2 (P450c11/aldosterone synthase) lead to integrated concept of zonal and temporal steroid biosynthesis.
Coulter CL; Jaffe RB
Endocrinology; 1998 Dec; 139(12):5144-50. PubMed ID: 9832454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
